Stephane Bancel insider trades

Open-market stock purchases and sales by Stephane Bancel, Chief Executive Officer at Moderna, Inc, from SEC Form 4 filings since Apr 14, 2022.

Recent trades

DateStockTradeValue
Aug 6, 2026MRNA Moderna, IncBought (not open market)$4.8M
Aug 6, 2026MRNA Moderna, IncBought (not open market)—
Aug 6, 2026MRNA Moderna, IncBought (not open market)—
Aug 5, 2026MRNA Moderna, IncSold$2.3M
Aug 5, 2026MRNA Moderna, IncSold$11M
Aug 5, 2026MRNA Moderna, IncBought (not open market)—
Aug 5, 2026MRNA Moderna, IncBought (not open market)—
Aug 5, 2026MRNA Moderna, IncBought (not open market)$9.6M
Aug 5, 2026MRNA Moderna, IncSold$8.3M
Aug 5, 2026MRNA Moderna, IncSold$7.1M
Mar 2, 2026GENB Generate Biomedicines, IncBought (not open market)—
Mar 2, 2026GENB Generate Biomedicines, IncBought (not open market)—
Mar 1, 2026MRNA Moderna, IncBought (not open market)—
Feb 26, 2026GENB Generate Biomedicines, IncBought (not open market)—
Feb 11, 2026MRNA Moderna, IncBought (not open market)—
Feb 11, 2026MRNA Moderna, IncSold (not open market)$229K
Dec 11, 2025MRNA Moderna, IncBought (not open market)—

Companies traded

  • MRNA Moderna, Inc: 2 buys, 656 sales, last Aug 6, 2026
  • GENB Generate Biomedicines, Inc: other filings, last Mar 2, 2026

Get free alerts when Stephane Bancel files a new trade →